Genmab AS
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -25.5% | +7.8% | +7.7% | +31.7% | +119.4% | -17.7% | -31.8% | +11.7% | -37.0% | +8.2% | +2.3% | +65.6% | +36.1% | +34.2% | +26.1% | +28.1% | +79.0% | +39.6% | +16.5% | +22.3% | +17.2% | +29.8% | -72.0% | |
| – | -24.8% | +11.7% | +11.0% | +33.8% | +121.2% | -49.8% | +9.6% | +12.2% | -37.3% | +9.0% | +2.4% | +63.4% | +32.6% | +33.5% | +23.7% | +22.7% | +87.8% | +34.6% | +21.0% | +24.1% | +17.4% | -15.9% | -89.7% | |
| – | +22.1% | +35.8% | -9.1% | +12.5% | -69.3% | -46.9% | +558.1% | -78.1% | -35.4% | +2.8% | +151.0% | +113.6% | +143.4% | -64.9% | +338.9% | -60.5% | +566.5% | +104.4% | +23.4% | +10.4% | +50.3% | -33.7% | -82.6% | |
| – | +22.1% | +35.8% | +198.6% | +37.6% | +114.2% | -98.1% | +1,724.9% | +29.1% | -33.3% | +36.6% | +3.5% | +70.9% | +31.3% | +12.3% | +38.3% | +12.6% | +79.7% | +46.6% | +20.3% | +15.4% | +26.0% | -25.0% | -91.9% | |
| – | – | – | – | – | – | -28.5% | – | – | +7.6% | +91.9% | -0.5% | -22.2% | +65.0% | +458.6% | -40.7% | +129.2% | +125.3% | -17.6% | +36.7% | +69.6% | -13.4% | +35.3% | -82.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | +8.8% | -71.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +11.7% | +252.3% | +42.8% | +155.6% | +77.8% | +32.5% | +35.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -86.0% | |
| – | -47.7% | -68.2% | – | – | – | – | – | – | – | – | – | +2,360.8% | +208.1% | -5.6% | -31.6% | +278.1% | -0.1% | -28.1% | -24.9% | -42.5% | -30.8% | +12,120.8% | -26.3% | |
| – | -49.1% | -2.9% | +176.8% | -21.7% | +445.8% | -0.5% | -13.6% | +51.6% | -23.1% | +21.5% | -18.1% | -22.2% | -50.1% | -1.0% | -19.6% | +35.0% | +145.4% | +84.5% | +20.2% | +16.7% | +29.7% | +147.7% | -23.1% | |
| – | -53.2% | -6.8% | +239.0% | -21.7% | +474.5% | -0.6% | -15.7% | +48.1% | -26.3% | +21.2% | -23.3% | -27.7% | -36.8% | -0.7% | -20.5% | +35.5% | +111.6% | +33.6% | +25.1% | +16.3% | +36.3% | +113.7% | -73.2% | |
| – | +76.8% | +44.4% | +6.3% | -18.7% | +7.6% | -23.4% | +22.1% | +1,640.0% | -90.5% | -67.4% | -43.5% | -88.9% | -50.2% | +52,113.6% | -100.0% | – | – | +61.5% | +47.6% | +19.4% | +21.6% | +2.2% | +216.3% | |
| – | -74.6% | -34.4% | -8.1% | +226.7% | +62.4% | +18.4% | -50.8% | -26.9% | +2.3% | +138.2% | +70.4% | -22.2% | -69.8% | -30.4% | +2,499.8% | +129.2% | +125.3% | -95.2% | +141.4% | +390.3% | +34.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -22.4% | +8.7% | -5.3% | +43.7% | +79.4% | -24.1% | -40.7% | -16.7% | -55.0% | -21.2% | +72.1% | +208.2% | +71.5% | +38.4% | +29.9% | +27.8% | +75.3% | +36.1% | +16.1% | +22.9% | +15.9% | +16.1% | -84.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +233.7% | +41.0% | +47.8% | +28.5% | +23.8% | -82.6% | |
| – | +2.2% | +15.9% | +18.1% | +24.5% | +12.9% | +1.6% | +0.6% | +0.0% | +0.0% | +2.5% | +12.7% | +10.3% | +6.2% | +1.6% | +0.5% | -0.1% | +2.6% | +3.5% | +0.2% | -0.1% | -0.1% | -1.9% | -3.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.